Protective Mechanism Pathway of <i>Swietenia macrophylla</i> Extract Nanoparticles against Cardiac Cell Damage in Diabetic Rats

Hyperglycemia causes cardiac cell damage through increasing ROS production during diabetic complications. The current study proves the antioxidant activity of <i>Swietenia macrophylla</i> (<i>S. macrophylla</i>) extract nanoparticles as a protector against streptozotocin (STZ...

Full description

Saved in:
Bibliographic Details
Main Authors: Rochmah Kurnijasanti (Author), Giftania Wardani (Author), Mohd. Rais Mustafa (Author), Sri Agus Sudjarwo (Author)
Format: Book
Published: MDPI AG, 2023-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Hyperglycemia causes cardiac cell damage through increasing ROS production during diabetic complications. The current study proves the antioxidant activity of <i>Swietenia macrophylla</i> (<i>S. macrophylla</i>) extract nanoparticles as a protector against streptozotocin (STZ)-induced cardiac cell damage. In this research, high-energy ball milling is used to create <i>S. macrophylla</i> extract nanoparticles. The active chemical compounds in the <i>S. macrophylla</i> extract nanoparticles were analyzed through phytochemical screening and GC-MS. Furthermore, we characterized the size of <i>S. macrophylla</i> extract nanoparticles with Dynamic Light Scattering (DLS). Forty male rats were divided randomly into five groups. In the control group, rats received aqua dest orally; in the diabetic group, rats were injected intraperitoneally with STZ; in the <i>S. macrophylla</i> group, rats were injected with STZ and orally given <i>S. macrophylla</i> extract nanoparticles. The results of phytochemical screening showed that <i>S. macrophylla</i> extract nanoparticles contain saponins, flavonoids, alkaloids, phenolics and tannins. Seven chemical compounds in <i>S. macrophylla</i> extract nanoparticles were identified using GC-MS, including phenol, piperidine, imidazole, hexadecene, heptadecanol, dihexylsulfide and heptanol. DLS showed that the <i>S. macrophylla</i> extract nanoparticles' size was 91.50 ± 23.06 nm. Injection with STZ significantly increased malondialdehyde (MDA) levels in cardiac tissue and creatine kinase-myocardial band (CK-MB) and lactate dehydrogenase (LDH) levels in serum. STZ also significantly reduced the expression of nuclear factor erythroid 2-related factor 2 (Nrf2) and the level of superoxide dismutase (SOD) and glutathione peroxidase (GPx) in cardiac tissue compared with the control group (<i>p</i> < 0.05). In contrast, the administration of <i>S. macrophylla</i> extract nanoparticles can prevent STZ-induced cardiac cell damage through decreasing the level of CK-MB and LDH in serum and the level of MDA in cardiac tissue. <i>S. macrophylla</i> extract nanoparticles also significantly increased Nrf2 expression as well as SOD and GPx levels in cardiac tissue. These effects are related to the prevention of cardiac histopathological alteration (degeneration and necrosis) in diabetic rats. These results suggest that <i>S. macrophylla</i> nanoparticles contain active compounds such as flavonoids, phenols, piperidine, imidazole and hexadecene and have strong antioxidant activity. These can act as a potential cardioprotective agent against STZ-induced cardiac cell damage due to its antioxidant properties.
Item Description:10.3390/ph16070973
1424-8247